JP2023507884A5 - - Google Patents
Info
- Publication number
- JP2023507884A5 JP2023507884A5 JP2022526044A JP2022526044A JP2023507884A5 JP 2023507884 A5 JP2023507884 A5 JP 2023507884A5 JP 2022526044 A JP2022526044 A JP 2022526044A JP 2022526044 A JP2022526044 A JP 2022526044A JP 2023507884 A5 JP2023507884 A5 JP 2023507884A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- nucleic acid
- element portion
- life extension
- life
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911038880.0A CN112746331A (zh) | 2019-10-29 | 2019-10-29 | 半衰期延长的药物及其文库、以及制备方法和应用 |
| CN201911038880.0 | 2019-10-29 | ||
| PCT/CN2020/123685 WO2021083077A1 (zh) | 2019-10-29 | 2020-10-26 | 半衰期延长的药物及其文库、以及制备方法和应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507884A JP2023507884A (ja) | 2023-02-28 |
| JP2023507884A5 true JP2023507884A5 (enExample) | 2024-01-30 |
| JP7588427B2 JP7588427B2 (ja) | 2024-11-22 |
Family
ID=75640992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526044A Active JP7588427B2 (ja) | 2019-10-29 | 2020-10-26 | 半減期が延長した薬物およびそのライブラリー、ならびに製造方法と使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230024592A1 (enExample) |
| EP (1) | EP4053311A4 (enExample) |
| JP (1) | JP7588427B2 (enExample) |
| KR (1) | KR102897184B1 (enExample) |
| CN (2) | CN112746331A (enExample) |
| AU (1) | AU2020374826B2 (enExample) |
| CA (1) | CA3166865A1 (enExample) |
| WO (1) | WO2021083077A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114539422B (zh) * | 2020-11-25 | 2024-03-29 | 安升（上海）医药科技有限公司 | 核酸多聚化介导的多价蛋白药物和疫苗的构建方法及应用 |
| CN115177740A (zh) * | 2021-04-01 | 2022-10-14 | 安升（上海）医药科技有限公司 | 核酸自组装介导的adc药物的构建方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8188223B2 (en) * | 2005-05-18 | 2012-05-29 | Ablynx N.V. | Serum albumin binding proteins |
| CA2673459C (en) * | 2006-12-22 | 2016-09-13 | Stefan Schulte | Modified coagulation factors with prolonged in vivo half-life |
| EP2655414B1 (en) * | 2010-12-23 | 2018-08-29 | Roche Diagniostics GmbH | Bispecific binding agent |
| SG191153A1 (en) * | 2010-12-23 | 2013-07-31 | Hoffmann La Roche | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
| CN102827277B (zh) * | 2012-04-26 | 2014-12-10 | 拜明(苏州)生物技术有限公司 | 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 |
| WO2014001326A1 (en) * | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof |
| CN108866635B (zh) * | 2017-05-09 | 2021-11-26 | 安升（上海）医药科技有限公司 | 多特异性蛋白药物及其文库、以及制备方法和应用 |
-
2019
- 2019-10-29 CN CN201911038880.0A patent/CN112746331A/zh active Pending
-
2020
- 2020-10-26 US US17/773,223 patent/US20230024592A1/en active Pending
- 2020-10-26 AU AU2020374826A patent/AU2020374826B2/en active Active
- 2020-10-26 CA CA3166865A patent/CA3166865A1/en active Pending
- 2020-10-26 WO PCT/CN2020/123685 patent/WO2021083077A1/zh not_active Ceased
- 2020-10-26 CN CN202080076758.7A patent/CN114630928A/zh active Pending
- 2020-10-26 KR KR1020227018321A patent/KR102897184B1/ko active Active
- 2020-10-26 JP JP2022526044A patent/JP7588427B2/ja active Active
- 2020-10-26 EP EP20883596.7A patent/EP4053311A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6105479B2 (ja) | 血清アルブミンに結合する設計リピートタンパク質 | |
| US7642044B2 (en) | Trimerising module | |
| KR100484084B1 (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| US8383575B2 (en) | (DI)barnase-barstar complexes | |
| AU2018266091B2 (en) | Multispecific protein drug and library thereof, preparing method therefor and application thereof | |
| JP2010534486A (ja) | 新規な組成物、方法および使用 | |
| JP2015535523A (ja) | アプロチニン由来ポリペプチド−抗体コンジュゲート | |
| JP7588427B2 (ja) | 半減期が延長した薬物およびそのライブラリー、ならびに製造方法と使用 | |
| JP2023507884A5 (enExample) | ||
| Park et al. | Single-chain variable fragments targeting domain II of human serum albumin for enhanced circulatory half-life via albumin association | |
| JP2024532602A (ja) | 天然分子に近いポリペプチド融合分子 | |
| JP7854204B2 (ja) | 新規ｉｉ型コラーゲン結合タンパク質 | |
| CN119019568A (zh) | 一种白蛋白结合型融合蛋白的制备及其用途 | |
| KR20220077590A (ko) | Candida Utilis 유래 요산산화효소-알부민 복합체 및 이의 제조 방법 | |
| HK40012160B (en) | Designed repeat proteins binding to serum albumin | |
| HK1189386B (zh) | 设计的与血清白蛋白结合的重复蛋白 |